Aβ fibrillogenesis:: Kinetic parameters for fibril formation from Congo red binding

被引:45
作者
Inouye, H [1 ]
Kirschner, DA [1 ]
机构
[1] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA
关键词
Alzheimer's beta-amyloid; fibril formation; kinetics; Congo red; nucleation-dependent self-assembly; Scatchard analysis;
D O I
10.1006/jsbi.2000.4258
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using Scatchard analysis, we have formulated as a function of time and pH the relationship between the binding of Congo red to Alzheimer's beta-amyloid and the aggregation number (i.e., monomer concentration within fibrils) as defined by nucleation-dependent self-assembly. This provides a basis on which to determine the kinetic parameters for fibril formation from the observed concentration of bound Congo red. (C) 2000 Academic Press.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 48 条
[1]  
ARVINTE T, 1993, J BIOL CHEM, V268, P6415
[2]  
Asakura S, 1970, Adv Biophys, V1, P99
[3]   Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides [J].
Ashburn, TT ;
Han, H ;
McGuinness, BF ;
Lansbury, PT .
CHEMISTRY & BIOLOGY, 1996, 3 (05) :351-358
[4]   SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA [J].
BARROW, CJ ;
YASUDA, A ;
KENNY, PTM ;
ZAGORSKI, MG .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) :1075-1093
[5]   KINETICS OF NUCLEATION-CONTROLLED POLYMERIZATION - A PERTURBATION TREATMENT FOR USE WITH A SECONDARY PATHWAY [J].
BISHOP, MF ;
FERRONE, FA .
BIOPHYSICAL JOURNAL, 1984, 46 (05) :631-644
[6]  
BURDICK D, 1992, J BIOL CHEM, V267, P546
[7]   A KINETIC-MODEL FOR AMYLOID FORMATION IN THE PRION DISEASES - IMPORTANCE OF SEEDING [J].
COME, JH ;
FRASER, PE ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5959-5963
[8]   APOLIPOPROTEIN-E IS A KINETIC BUT NOT A THERMODYNAMIC INHIBITOR OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF ALZHEIMER-DISEASE [J].
EVANS, KC ;
BERGER, EP ;
CHO, CG ;
WEISGRABER, KH ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :763-767
[9]   CONFORMATION AND FIBRILLOGENESIS OF ALZHEIMER A-BETA PEPTIDES WITH SELECTED SUBSTITUTION OF CHARGED RESIDUES [J].
FRASER, PE ;
MCLACHLAN, DR ;
SUREWICZ, WK ;
MIZZEN, CA ;
SNOW, AD ;
NGUYEN, JT ;
KIRSCHNER, DA .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 244 (01) :64-73
[10]   MORPHOLOGY AND ANTIBODY RECOGNITION OF SYNTHETIC BETA-AMYLOID PEPTIDES [J].
FRASER, PE ;
DUFFY, LK ;
OMALLEY, MB ;
NGUYEN, J ;
INOUYE, H ;
KIRSCHNER, DA .
JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 28 (04) :474-485